Telaprevir for Chronic HCV Infection REPLY

被引：0
|
作者：
McHutchison, John [1 ]
Pawlotsky, Jean-Michel [2 ]
Zeuzem, Stefan [3 ]
机构：
[1] Duke Univ, Durham, NC 27715 USA
[2] Henri Mondor Univ Hosp, F-94010 Creteil, France
[3] JW Goethe Univ Hosp, D-60590 Frankfurt, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 05期
关键词：
HEPATITIS-C;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：534 / 535
页数：2
相关论文
共 50 条
  • [21] The impact of antiviral therapy on the course of chronic HCV infection -: A systematic review
    Almasio, PL
    Venezia, G
    Craxì, A
    PANMINERVA MEDICA, 2003, 45 (03) : 175 - 182
  • [22] Differential dysfunction in dendritic cell subsets during chronic HCV infection
    Averill, Lynn
    Lee, William M.
    Karandikar, Nitin J.
    CLINICAL IMMUNOLOGY, 2007, 123 (01) : 40 - 49
  • [23] A Case of Chronic HCV Infection Reactivation in a Psoriasis Patient Treated with Guselkumab
    Megna, Matteo
    Fabbrocini, Gabriella
    Gallo, Lucia
    Patri, Angela
    Ruggiero, Angelo
    CURRENT DRUG SAFETY, 2022, 17 (04) : 390 - 392
  • [24] Ombitasvir/Paritaprevir/Ritonavir: A Review in Chronic HCV Genotype 4 Infection
    Keating, Gillian M.
    DRUGS, 2016, 76 (12) : 1203 - 1211
  • [25] Response to the comment made on Treatment of HCV infection in chronic kidney disease
    Garcia Agudo, R.
    Aoufi Rabih, S.
    NEFROLOGIA, 2011, 31 (05): : 607 - 608
  • [26] The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir
    Marks, Kristen M.
    Jacobson, Ira M.
    ANTIVIRAL THERAPY, 2012, 17 (06) : 1119 - 1131
  • [27] Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV
    Tempestilli, Massimo
    Milano, Elisa
    D'Offizi, Gianpiero
    Montalbano, Marzia
    D'Avolio, Antonio
    Gasperi, Tecla
    Narciso, Pasquale
    Ascenzi, Paolo
    Pucillo, Leopoldo P.
    IUBMB LIFE, 2013, 65 (09) : 800 - 805
  • [28] Severity of HCV-induced liver damage alters glucose homeostasis in noncirrhotic patients with chronic HCV infection
    Konrad, T
    Zeuzem, S
    Toffolo, G
    Vicini, P
    Teuber, G
    Briem, D
    Lormann, J
    Lenz, T
    Herrmann, G
    Berger, A
    Cobelli, C
    Usadel, KH
    DIGESTION, 2000, 62 (01) : 52 - 59
  • [29] Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: Is it feasible?
    Dumortier, Jerome
    Guillaud, Olivier
    Gagnieu, Marie-Claude
    Janbon, Benedicte
    Juillard, Laurent
    Morelon, Emmanuel
    Leroy, Vincent
    JOURNAL OF CLINICAL VIROLOGY, 2013, 56 (02) : 146 - 149
  • [30] Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype I infection: an indirect comparison meta-analysis
    Cooper, Curtis L.
    Druyts, Eric
    Thorlund, Kristian
    Nachega, Jean B.
    El Khoury, Antoine C.
    O'Regan, Christopher
    Mills, Edward J.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 105 - 130
12345